ES505496A0 - Un procedimiento para preparar nuevos compuestos de cefem - Google Patents

Un procedimiento para preparar nuevos compuestos de cefem

Info

Publication number
ES505496A0
ES505496A0 ES505496A ES505496A ES505496A0 ES 505496 A0 ES505496 A0 ES 505496A0 ES 505496 A ES505496 A ES 505496A ES 505496 A ES505496 A ES 505496A ES 505496 A0 ES505496 A0 ES 505496A0
Authority
ES
Spain
Prior art keywords
procedure
preparing new
cefem compounds
new cefem
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES505496A
Other languages
English (en)
Other versions
ES8205810A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES505496A0 publication Critical patent/ES505496A0/es
Publication of ES8205810A1 publication Critical patent/ES8205810A1/es
Priority claimed from AU23283/84A external-priority patent/AU2328384A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/26—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/263—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/21—Radicals derived from sulfur analogues of carbonic acid
ES505496A 1979-10-12 1981-09-15 Un procedimiento para preparar nuevos compuestos de cefem Expired ES8205810A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7935538 1979-10-12
AU23283/84A AU2328384A (en) 1978-12-29 1984-01-13 1,2,4-thiadiazole derivatives

Publications (2)

Publication Number Publication Date
ES505496A0 true ES505496A0 (es) 1982-07-16
ES8205810A1 ES8205810A1 (es) 1982-07-16

Family

ID=32962949

Family Applications (1)

Application Number Title Priority Date Filing Date
ES505496A Expired ES8205810A1 (es) 1979-10-12 1981-09-15 Un procedimiento para preparar nuevos compuestos de cefem

Country Status (3)

Country Link
US (1) US4338313A (es)
ES (1) ES8205810A1 (es)
ZA (1) ZA806068B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61679B1 (en) * 1987-08-10 1994-11-16 Fujisawa Pharmaceutical Co Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
EP2862569A1 (en) 2011-09-09 2015-04-22 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079178A (en) * 1971-05-14 1978-03-14 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino) acylamido groups at the 7-position
US4093803A (en) * 1971-05-14 1978-06-06 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-, furyl- or pyridylacetamido)] cephalosporins
US3821207A (en) * 1971-06-21 1974-06-28 Smithkline Corp 7-heterocyclic substituted cephalosporins
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
CA1088049A (en) * 1975-06-03 1980-10-21 Takashi Masugi 3-substituted-7-substituted alkanamido-3-cephem-4- carboxylic acid compounds and processes for preparation thereof
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
GB1592149A (en) * 1976-10-08 1981-07-01 Fujisawa Pharmaceutical Co 3 7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for preparation thereof
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato

Also Published As

Publication number Publication date
US4338313A (en) 1982-07-06
ZA806068B (en) 1981-09-30
ES8205810A1 (es) 1982-07-16

Similar Documents

Publication Publication Date Title
ES496948A0 (es) Un procedimiento para preparar compuestos de cefem
ES491998A0 (es) Un procedimiento para preparar compuestos aromaticos susti- tuidos
AR226837A1 (es) Un procedimiento para la obtencion de un aglutinante histico
ES495376A0 (es) Un procedimiento para preparar un compuesto de 1,8-naftiri- dina
ES497084A0 (es) Un procedimiento para preparar nuevos compuestos de tiazol.
ES489222A0 (es) Un procedimiento para preparar un compuesto de guanidinotia-zol
ES490503A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES493061A0 (es) Un procedimiento para preparar un lipopolisacarido
ES490166A0 (es) Un procedimiento para preparar mercaptoacildipeptidos
ES527790A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES492002A0 (es) Un procedimiento para preparar compuestos de cefem
ES497303A0 (es) Un procedimiento para preparar 9-aminoalquilfluorenos
ES503134A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES494459A0 (es) Un procedimiento para preparar cetoximinoeteres
ES505498A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES505496A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES494629A0 (es) Un procedimiento para preparar compuestos de tiofosfonato nosimetricos
AR226127A1 (es) Procedimiento para producir un compuesto de piran-4-ona
ES493798A0 (es) Un procedimiento para preparar 7-alcoxicarbonil-6,8-dime- til-4-hidroximetil-1-ftalazona
ES496859A0 (es) Un procedimiento para preparar derivados de halofenil-piri- dilalilamina
ES488808A0 (es) Un procedimiento para preparar derivados de fenotiazina
ES505714A0 (es) Un procedimiento para preparar compuestos de cefem
ES498168A0 (es) Un procedimiento para preparar alcohilfosfonoditioato de al-cohilo
AR224652A1 (es) Un procedimiento para preparar derivados de decahidroquinolinol
ES495795A0 (es) Un procedimiento para preparar nuevos compuestos de cefem